Remove Development Remove Meeting Remove Metrics Remove Pharmaceuticals
article thumbnail

Wearable Technology in Healthcare

Tom Spencer

2 As questions on how to rein in increasing healthcare costs continue to mount, and politicians focus on passing legislation and targeting the pharmaceutical industry, a possible solution may be wearable health devices. Offers include things like gift cards and small cash payments for meeting certain daily fitness goals.

article thumbnail

Fixing Pharma’s Incentives Problem in the Wake of the U.S. Opioid Crisis

Harvard Business

Since 1999, three years after OxyContin was unveiled by Purdue Pharmaceuticals, the rate of drug overdoses in the U.S. Meanwhile, the amount of prescription opioids sold by pharmaceutical companies has quadrupled, despite no proliferation in the amount of reported pain.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How Digital Health Care Can Help Prevent Chronic Diseases Like Diabetes

Harvard Business

million adults in the United States with high blood sugar levels in danger of developing type 2 diabetes. DPPs typically include in-person meetings of a small group of prediabetic adults who, with the guidance of a health coach, progress through a diet and lifestyle curriculum. In addition there are 84.1

article thumbnail

Change Management Is Becoming Increasingly Data-Driven. Companies Aren’t Ready

Harvard Business

At EY, where some of us work, we have developed a tool for social media analytics called SMAART that is able to understand sentiment within consumer and influencer groups. What is the cause and effect of specific types of investment — for example, leadership development, large group events, and communications cascades?

article thumbnail

Is Your Company as Ethical as It Seems?

Harvard Business

You are the newly promoted vice president of business development at an oil company. Despite having solid internal anti-corruption rules in place, the pharmaceutical giant wound up facing criminal investigations for bribing doctors and foreign officials , eventually paying a $489 million fine. Picture this. Consider the case of GSK.

Ethics 28
article thumbnail

To Seize the Future, Create a Leadership Circle

Harvard Business

A global pharmaceutical company was about to lose the strategic advantage of several blockbuster drugs coming off patent. Lastly, this group may be more attuned to individual interests (including performance metrics and compensation incentives) rather than the collective and longer-term needs of the firm. paul Garbett for HBR.

article thumbnail

7 Ways to Improve Operations Without Sacrificing Worker Safety

Harvard Business

I was pleased with our meeting, feeling like she had made a real commitment. At his first meeting with employees, however, he announced that he wasn’t going to begin by talking about the firm’s financial challenges. Each firm needs to select or develop its own, appropriate to its functions and products.